Angle PLC Sustainability Reports
A liquid biopsy company focused on circulating tumor cell (CTC) diagnostic solutions for use in research, drug development, and clinical oncology.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
LEI: 213800BY11K6W3NMS374
FIGI: BBG001SJWTQ8
11 reports from 2017 to 2025
